// App-Quantinova.ai

150 : Auto‐immunity to C1q: A marker of a subset of idiopathic angioedema

Researchers

Presenter

  • Monnickendam A

Principal Investigators

  • Wagner A

Medical Centers

  • University of Cambridge, Cambridge, United Kingdom

  • Addenbrookes Hospital, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • C1 Inhibitor Deficiency

Biomarkers

  • Complement 3

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A